Homocysteine, 5,10-méthylénetétrahydrofolate reductase et thrombose veineuse profonde. Enquête auprès de 120 patients en médecine interne

This publication has 11 references indexed in Scilit:

• Thrombophilia, Homocystinuria, and Mutation of the Factor V Gene
  New England Journal of Medicine, 1996
• Hyperhomocysteinemia as a Risk Factor for Deep-Vein Thrombosis
  New England Journal of Medicine, 1996
• Coexistence of Hereditary Homocystinuria and Factor V Leiden — Effect on Thrombosis
  New England Journal of Medicine, 1996
• Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study
  The Lancet, 1995
• Prevalence of Moderate Hyperhomocysteinemia in Patients with Early-Onset Venous and Arterial Occlusive Disease
  Annals of Internal Medicine, 1995
• A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes
  Published by American Medical Association (AMA) ,1995
• A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase
  Nature Genetics, 1995
• Is hyperhomocysteinaemia a risk factor for recurrent venous thrombosis?
  The Lancet, 1995
• High prevalence of hyperhomocyst(e)inemia in patients with juvenile venous thrombosis.
  Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994
• Folic acid—an innocuous means to reduce plasma homocysteine
  Scandinavian Journal of Clinical and Laboratory Investigation, 1988